Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 100 shares at $30.00 ($3K) on 2025-03-07, disclosed to the SEC on 2025-03-11.
Scheduled sale ($3k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EWTX | SELL | 2025-05-07 | $141K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $119K | — | Filing → |